Stay updated on Preop Pembrolizumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Administrative updates were made: addition of Revision: v3.4.2 and removal of a government funding lapse notice and an earlier Revision: v3.4.1. These updates do not alter the trial details or core information.
    Difference
    0.4%
    Check dated 2026-02-12T01:36:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Additions include a site-wide government funding notice and a revision update (v3.4.1); the deletion removes the previous revision (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T11:31:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Show glossary toggle was added and new metadata labels Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0 were introduced, while Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 labels were removed.
    Difference
    0.2%
    Check dated 2026-01-28T11:10:31.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page shows a minor revision update: Revision v3.3.4 was added and Revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:52:19.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The study record shows termination and results posted on 2025-12-31, and adds detailed objectives and perioperative treatment plans for pembrolizumab plus vactosertib in colorectal cancer with resectable liver metastases.
    Difference
    4%
    Check dated 2026-01-07T01:57:12.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Locations now include California; the California Locations subsection and the HHS Vulnerability Disclosure link were removed, and the revision was updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:39:29.000Z thumbnail image

Stay in the know with updates to Preop Pembrolizumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.